Prof. Dr. med. Axel S. Merseburger
Prof. Dr. med. Axel S. Merseburger
Universität Lübeck
Verified email at
Cited by
Cited by
EAU guidelines on renal cell carcinoma: 2014 update
B Ljungberg, K Bensalah, S Canfield, S Dabestani, F Hofmann, M Hora, ...
European urology 67 (5), 913-924, 2015
European association of urology guidelines on renal cell carcinoma: the 2019 update
B Ljungberg, L Albiges, Y Abu-Ghanem, K Bensalah, S Dabestani, ...
European urology 75 (5), 799-810, 2019
Apalutamide for metastatic, castration-sensitive prostate cancer
KN Chi, N Agarwal, A Bjartell, BH Chung, AJ Pereira de Santana Gomes, ...
New England Journal of Medicine 381 (1), 13-24, 2019
Renal cell carcinoma guideline
B Ljungberg, DC Hanbury, MA Kuczyk, AS Merseburger, PFA Mulders, ...
European urology 51 (6), 1502-1510, 2007
Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines
A Stenzl, NC Cowan, M De Santis, MA Kuczyk, AS Merseburger, MJ Ribal, ...
European urology 59 (6), 1009-1018, 2011
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration
W Abida, A Patnaik, D Campbell, J Shapiro, AH Bryce, R McDermott, ...
Journal of Clinical Oncology 38 (32), 3763-3772, 2020
Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy
L Marconi, S Dabestani, TB Lam, F Hofmann, F Stewart, J Norrie, A Bex, ...
European urology 69 (4), 660-673, 2016
The updated EAU guidelines on muscle-invasive and metastatic bladder cancer
A Stenzl, NC Cowan, M De Santis, G Jakse, MA Kuczyk, AS Merseburger, ...
European urology 55 (4), 815-825, 2009
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
T Powles, T Csőszi, M Özgüroğlu, N Matsubara, L Géczi, SYS Cheng, ...
The Lancet Oncology 22 (7), 931-945, 2021
Non-BRCA DNA damage repair gene alterations and response to the PARP inhibitor rucaparib in metastatic castration-resistant prostate cancer: analysis from the phase II TRITON2 …
W Abida, D Campbell, A Patnaik, JD Shapiro, B Sautois, NJ Vogelzang, ...
Clinical Cancer Research 26 (11), 2487-2496, 2020
Apalutamide in patients with metastatic castration-sensitive prostate cancer: final survival analysis of the randomized, double-blind, phase III TITAN study
KN Chi, S Chowdhury, A Bjartell, BH Chung, ...
Journal of Clinical Oncology 39 (20), 2294-2303, 2021
EAU guidelines on laser technologies
TRW Herrmann, EN Liatsikos, U Nagele, O Traxer, AS Merseburger, ...
European urology 61 (4), 783-795, 2012
Impact of gender on bladder cancer incidence, staging, and prognosis
H Fajkovic, JA Halpern, EK Cha, A Bahadori, TF Chromecki, ...
World journal of urology 29, 457-463, 2011
MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies
AG Anastasiadis, MP Lichy, U Nagele, MA Kuczyk, AS Merseburger, ...
European urology 50 (4), 738-749, 2006
Current evidence of transurethral en-bloc resection of nonmuscle invasive bladder cancer
MW Kramer, V Altieri, R Hurle, L Lusuardi, AS Merseburger, J Rassweiler, ...
European urology focus 3 (6), 567-576, 2017
Updated European Association of Urology guidelines on renal cell carcinoma: immune checkpoint inhibition is the new backbone in first-line treatment of metastatic clear-cell …
L Albiges, T Powles, M Staehler, K Bensalah, RH Giles, M Hora, ...
European urology 76 (2), 151-156, 2019
Updated European Association of Urology Guidelines: recommendations for the treatment of first-line metastatic clear cell renal cancer
T Powles, L Albiges, M Staehler, K Bensalah, S Dabestani, RH Giles, ...
European urology 73 (3), 311-315, 2018
En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc …
MW Kramer, JJ Rassweiler, J Klein, A Martov, N Baykov, L Lusuardi, ...
World journal of urology 33, 1937-1943, 2015
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised …
T Powles, P Tomczak, SH Park, B Venugopal, T Ferguson, ...
The lancet oncology 23 (9), 1133-1144, 2022
EAU guidelines on robotic and single-site surgery in urology
AS Merseburger, TRW Herrmann, SF Shariat, I Kyriazis, U Nagele, ...
European urology 64 (2), 277-291, 2013
The system can't perform the operation now. Try again later.
Articles 1–20